BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2735936)

  • 1. Vesicular accumulation of dopamine following L-DOPA administration.
    Buu NT
    Biochem Pharmacol; 1989 Jun; 38(11):1787-92. PubMed ID: 2735936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors.
    Buu NT
    Biochem Pharmacol; 1989 May; 38(10):1685-92. PubMed ID: 2730683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular and ganglionic norepinephrine in the rat: progressive increase with age.
    Buu NT; Debinski W
    J Neurochem; 1990 Feb; 54(2):620-6. PubMed ID: 2299355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
    Buu NT; Lussier C
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):563-8. PubMed ID: 2748880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentation of catecholamines in rat brain: effects of agonists and antagonists.
    Hartman JA; Halaris AE
    Brain Res; 1980 Nov; 200(2):421-36. PubMed ID: 7417823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 3-OM-dopa on monoamine metabolism in rat brain.
    Gervas JJ; Muradás V; Bazán E; Aguado EG; de Yébenes JG
    Neurology; 1983 Mar; 33(3):278-82. PubMed ID: 6681870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
    Buu NT; Angers M; Duhaime J; Kuchel O
    J Neural Transm; 1987; 70(1-2):39-50. PubMed ID: 3668521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in L-DOPA evoked dopamine and DOPAC output under conditions of impaired vesicular dopamine storage.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1998; 105(10-12):1091-101. PubMed ID: 9928880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-dopamine accumulation by rat brain synaptic vesicles in a membrane-impermeable medium.
    Gershten MJ; Disbrow JK; Ruth JA
    Life Sci; 1983 Jul; 33(4):323-9. PubMed ID: 6877025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine sulfoconjugation in the rat brain: regulation by monoamine oxidase.
    Buu NT
    J Neurochem; 1985 Aug; 45(2):470-6. PubMed ID: 3925084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of yohimbine on brain monoamines: an in vivo study.
    Brannan T; Martinez-Tica J; Yahr MD
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):81-7. PubMed ID: 1716906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of dopamine in the rat adrenal cortex.
    Buu NT; Lussier C
    Am J Physiol; 1990 Feb; 258(2 Pt 2):F287-91. PubMed ID: 2106792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of dopamine metabolism by in vivo voltammetry and high performance liquid chromatography in L-dopa-treated rats.
    Aoki S; Inukai K; Sakurai M; Koshikawa N; Kobayashi M
    Jpn J Pharmacol; 1987 Jan; 43(1):98-102. PubMed ID: 3573420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outflow of dopamine and noradrenaline originating from L-dopa and L-threo-DOPS in rat renal tissues.
    Pestana M; Soares-Da-Silva P
    Gen Pharmacol; 1994 Sep; 25(5):879-85. PubMed ID: 7835631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.